According to our genome-wide transcriptomic analysis and Q-PCR validation, we found that the DNA damage-related genes ERCC1, XPC, and CRY1 were up-regulated in hinokitiol-treated lung cancer cells. The gene discussed is XPC; the disease is lung carcinoma.